Lista de obras - Marzia Varettoni - Dominio Público Uruguay

A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

artículo científico publicado en 2007

A revised international prognostic score system for Waldenström's macroglobulinemia

artículo científico publicado en 2019

A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Walde

scientific article published on 05 July 2019

Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases

article

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

artículo científico publicado en 2014

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

artículo científico publicado en 2010

Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.

artículo científico publicado en 2013

Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.

artículo científico publicado en 2015

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

artículo científico publicado en 2015

Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature.

artículo científico publicado en 2017

Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies

artículo científico publicado en 2014

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived.

artículo científico publicado en 2009

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

artículo científico publicado en 2009

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

artículo científico publicado en 2016

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

artículo científico publicado en 2015

Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

artículo científico publicado en 2006

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients

artículo científico publicado en 2010

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network

artículo científico publicado en 2019

Clinical characteristics and outcome of immunoglobulin M-related disorders.

artículo científico publicado en 2005

Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia

artículo científico publicado en 2015

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

artículo científico publicado en 2013

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.

artículo científico publicado en 2008

Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia

scientific article published on 07 September 2018

Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.

artículo científico publicado en 2011

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

artículo científico publicado en 2019

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.

artículo científico publicado en 2008

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

artículo científico publicado en 2007

Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.

artículo científico publicado en 2010

Factors predicting transformation of asymptomatic IgM monoclonal gammopathy

artículo científico publicado en 2011

Flexural erythematous eruption following autologous peripheral blood stem cell transplantation: a study of four cases.

artículo científico publicado en 2001

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

artículo científico publicado en 2011

Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.

artículo científico publicado en 2013

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

artículo científico publicado en 2018

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

artículo científico publicado en 2005

Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma

artículo científico publicado en 2016

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

artículo científico publicado en 2009

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy.

artículo científico publicado en 2007

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

artículo científico publicado en 2019

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2013

Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

artículo científico

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.

artículo científico publicado en 2004

Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia

artículo científico publicado en 2020

Monoclonal gammopathy of undetermined significance: a new proposal of workup.

artículo científico publicado en 2013

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

artículo científico publicado en 2020

Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal

artículo científico publicado en 2004

Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls.

artículo científico publicado en 2004

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2017

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

artículo científico publicado en 2008

Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies

scientific article published on 01 March 2005

Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.

artículo científico publicado en 2007

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

artículo científico publicado en 2016

Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.

artículo científico publicado en 2004

Risk of second cancers in Waldenström macroglobulinemia ⬇️

artículo científico publicado el 27 de abril de 2011

Severe intestinal vasculitis in a patient under treatment with bortezomib

artículo científico publicado en 2007

Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.

artículo científico publicado en 2015

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

artículo científico publicado en 2011

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

artículo científico publicado en 2014

The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis

artículo científico publicado en 2011

The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?

artículo científico publicado en 2007

The possible role of burden of therapy on the risk of myeloma extramedullary spread

artículo científico publicado en 2016

Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant ⬇️

artículo científico publicado el 1 de septiembre de 2001

Thrombomodulin levels are not modified during thalidomide treatment

artículo científico publicado en 2006

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies

artículo científico publicado en 2020

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.

artículo científico publicado en 2005

mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in

article

Lista de obras de Marzia Varettoni

A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma

A revised international prognostic score system for Waldenström's macroglobulinemia

A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Walde

Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.

Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature.

Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived.

Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients.

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.

Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network

Clinical characteristics and outcome of immunoglobulin M-related disorders.

Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia

Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients.

Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia

Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.

Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

Emergent T-helper 2 profile with high interleukin-6 levels correlates with the appearance of bortezomib-induced neuropathic pain.

Factors predicting transformation of asymptomatic IgM monoclonal gammopathy

Flexural erythematous eruption following autologous peripheral blood stem cell transplantation: a study of four cases.

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects.

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy.

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone.

Monoclonal gammopathy and serum immunoglobulin levels as prognostic factors in chronic lymphocytic leukaemia

Monoclonal gammopathy of undetermined significance: a new proposal of workup.

Nonlymphoplasmacytic lymphomas associated with light-chain amyloidosis

Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal

Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls.

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies

Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies.

Risk of second cancers in Waldenström macroglobulinemia ⬇️

Severe intestinal vasculitis in a patient under treatment with bortezomib

Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome.

The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.

The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection

The impact of advanced age according to IPSSWM cut-off on the outcome of symptomatic and asymptomatic Waldenström's macroglobulinemia at diagnosis

The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Thiotepa and fludarabine (TT-FLUDA) as conditioning regimen in poor candidates for conventional allogeneic hemopoietic stem cell transplant ⬇️

Thrombomodulin levels are not modified during thalidomide treatment

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.

mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in